Patent · US Expired

Formulation containing anti-inflammatory androstane derivative

US6858596B2 · kind B2 · utility

10Cited by
44References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2002
Grant dateFeb 22, 2005
Priority date—
Expiry dateMar 10, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.